Consequently, it was speculated that hsa_circ_0012152 might participate in the progression of AML by inhibiting the expression of miR-491-5p or miR-512-3p, promoting the expression of EGFR and MAPK1 and eventually activating the MAPK pathway. Here, EGFR is linked to acute myeloid leukemia.